Welcome to Best Pharmacy at Havmeds! Go shopping!

Product ID: 971828

Reminder: The pictures displayed on this site maybe different from the actual appearance of the product,their maybe a delay in updating the recent picture if their a newly launched packaging from the manufacturer


Myhepall is used to treat chronic hepatitis C virus (HCV) infection. Sofosbuvir + Velpatasvir is a drug that combines two antiviral medications.

Trade name
Main ingreadient
Velpatasvir and Sofosbuvir
(400mg+100mg)*28 Tablets
Please negotiate the logistics method with customer service, customer service Whatsapp/Wechat
Please follow the doctor’s advice when taking medicines. The mall only guarantees the quality of the medicines and does not provide medical advice.

Authenticity guarantee

India Direct Mail

Privacy packaging

Pharmacy Direct


Myhepall operate by reducing hepatitis C virus levels in the body and eliminating the virus from the blood over time. Sofosbuvir-velpatasvir is a single-pill combination of pangenotypic NS5A-NS5B inhibitors that has potent action against HCV genotypes 1, 2, 3, 4, 5, and 6. It gives patients with HCV genotype 3 infection, particularly those with compensated cirrhosis, a much-needed choice. Except in conjunction with a third agent, sofosbuvir-velpatasvir has not been examined for any of the genotypes for an abbreviated duration of 8 weeks (voxilaprevir). Acid-reducing medications, particularly proton-pump inhibitors, may have dramatically lowered levels of sofosbuvir-velpatasvir, similar to ledipasvir-sofosbuvir.
One tablet (400 mg sofosbuvir and 100 mg velpatasvir) taken orally once a day with or without food is the suggested dosage for adults.
Related Products
Copyright 2023 havmeds.com. All Rights Reserved
Call Us